Also, as stated by Furukawa (2019), although reports on the frequency of NMS in these individuals remain conflicting, in general, intellectual and cognitive function is typical in individuals with DYT/PARK-GCH1 [12]. This evidence concerns the gene GCH1 and neuroleptic malignant syndrome.